bit.bio’s mission is coding cells for health. To do so, they apply the principles of computation to biology.
What you'll be doing
Supporting the design, development and implementation of a state-of-the-art cellular engineering platform. This includes assay design, implementation and execution.
LIMS/sample tracking, resource management, SOP and process development.
Being accountable for cell line and reagent delivery to a wide variety of stake holders; internal scientific, manufacturing and external academic and contract research organisations.
Engaging and influencing external collaborators (and suppliers). Being involved in initiating, developing and driving collaborations which are critical to the achievement of the team and company Objectives and Key Results (OKRs).
Influencing and impacting across the wider scientific and manufacturing teams as pertains to gene engineering and cell line development and may sit on a number of key committees.
Overseeing development and training activities; coach individuals to perform their roles effectively.
Actively leading in developing and maintaining the core cultural aspects of the company.
A PhD in a relevant area of Biological Sciences or equivalent experience and a passion for problem solving.
Strong practical and theoretical background in ESC or HiPSC culture.
Strong practical and theoretical background in editing ESC, HiPSCs and mammalian cells – experimental quality control and project delivery (>2 years of experience).
Ability to manage and prioritise own workload.
Experience of coaching, training and development.
Well-rounded practical experience and knowledge of cellular assays and cell phenotyping (FACS, IHC, clonogenic, cytotoxicity and viability).
The ability to effectively communicate with collaborators and occasionally present to large groups.
(Desirable) Experience in the use and incorporation of automated workflows.
(Desirable) Experience in working with IT and informatics teams to develop sample and experiment tracking software/systems.
Our current focus is to develop a scalable technology platform capable of producing consistent batches of every human cell. This has the potential to unlock a new generation of medicine: it will enable research and drug discovery to move on from inappropriate models and work with the cells that actually are affected by human disease. A scalable platform of consistent cells will also be the basis for a new generation of cell and tissue therapies.
To achieve our goals, we have assembled a team of pioneers in stem cells, cellular reprogramming, mathematical modelling, and cell therapy.
Collaboration is at the heart of bit.bio. We are empirical, highly ambitious and driven by a common purpose.